RA0194

antibody from Oursmab

Targeting: EGFR ERBB, ERBB1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0194

Provider

Oursmab

Product name

Cetuximab (Biosimilar Reference Antibody) (EGFR)

Antibody type

Monoclonal

Description

Cetuximab is a chimeric (mouse/human) monoclonal antibody used as a targeted therapy for certain types of cancer. Marketed under the brand name Erbitux?, it is approved for the treatment of squamous cell carcinoma of the head and neck (SCCHN) and KRAS wild-type, metastatic colorectal cancer (mCRC). It can be used in combination with radiation therapy for locally advanced SCCHN, with chemotherapy for recurrent or metastatic SCCHN and mCRC, or as a monotherapy in patients who have failed prior treatments. Cetuximab works by inhibiting the signaling pathway that drives tumor cell growth and proliferation.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.